{"id":"https://openalex.org/W1850971799","doi":"https://doi.org/10.1212/wnl.84.14_supplement.p7.065","title":"Acthar in Dermatomyositis and Polymyositis Treatment Registry: An Interim Analysis (P7.065)","display_name":"Acthar in Dermatomyositis and Polymyositis Treatment Registry: An Interim Analysis (P7.065)","publication_year":2015,"publication_date":"2015-04-06","ids":{"openalex":"https://openalex.org/W1850971799","doi":"https://doi.org/10.1212/wnl.84.14_supplement.p7.065","mag":"1850971799"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.84.14_supplement.p7.065","doi":"https://doi.org/10.1212/wnl.84.14_supplement.p7.065","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.84.14_supplement.p7.065","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112266809","display_name":"Todd Levine","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140312","display_name":"Phoenix Neurological Associates","ror":"https://ror.org/04hk0mm26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210140312"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Todd Levine","raw_affiliation_strings":["Phoenix Neurological Associates Ltd Phoenix AZ United States","1Phoenix Neurological Associates Ltd Phoenix AZ United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phoenix Neurological Associates Ltd Phoenix AZ United States","institution_ids":["https://openalex.org/I4210140312"]},{"raw_affiliation_string":"1Phoenix Neurological Associates Ltd Phoenix AZ United States","institution_ids":["https://openalex.org/I4210140312"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5112266809"],"corresponding_institution_ids":["https://openalex.org/I4210140312"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.05972242,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"84","issue":"14_supplement","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11724","display_name":"Inflammatory Myopathies and Dermatomyositis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11724","display_name":"Inflammatory Myopathies and Dermatomyositis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11271","display_name":"Myasthenia Gravis and Thymoma","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10441","display_name":"Muscle Physiology and Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tetracosactide","display_name":"tetracosactide","score":0.7459999918937683},{"id":"https://openalex.org/keywords/dermatomyositis","display_name":"dermatomyositis","score":0.871999979019165},{"id":"https://openalex.org/keywords/polymyositis","display_name":"polymyositis","score":1.0},{"id":"https://openalex.org/keywords/refractory-myositis","display_name":"refractory myositis","score":0.8679999709129333},{"id":"https://openalex.org/keywords/acth-therapy","display_name":"ACTH therapy","score":0.7639999985694885},{"id":"https://openalex.org/keywords/melanocortin-receptors","display_name":"melanocortin receptors","score":0.9129999876022339},{"id":"https://openalex.org/keywords/steroid-sparing-therapy","display_name":"steroid-sparing therapy","score":0.8709999918937683},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6869999766349792},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.9440000057220459},{"id":"https://openalex.org/keywords/lower-extremity-edema","display_name":"lower limb edema","score":0.8659999966621399},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.6119999885559082},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.7419999837875366}],"concepts":[{"id":"https://openalex.org/C2779387793","wikidata":"https://www.wikidata.org/wiki/Q980926","display_name":"Polymyositis","level":2,"score":0.9521112442016602},{"id":"https://openalex.org/C2778751314","wikidata":"https://www.wikidata.org/wiki/Q681160","display_name":"Dermatomyositis","level":2,"score":0.93880295753479},{"id":"https://openalex.org/C2776957806","wikidata":"https://www.wikidata.org/wiki/Q4895105","display_name":"Interim","level":2,"score":0.841825008392334},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7618778944015503},{"id":"https://openalex.org/C61943457","wikidata":"https://www.wikidata.org/wiki/Q6046661","display_name":"Interim analysis","level":3,"score":0.7107949256896973},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.36466842889785767},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.31998714804649353},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3191951811313629},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2632454037666321},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.08144232630729675},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1212/wnl.84.14_supplement.p7.065","doi":"https://doi.org/10.1212/wnl.84.14_supplement.p7.065","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.84.14_supplement.p7.065","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2519002891","https://openalex.org/W140474272","https://openalex.org/W4360983727","https://openalex.org/W1999494306","https://openalex.org/W2402352225","https://openalex.org/W2406778582","https://openalex.org/W2436259342","https://openalex.org/W3033208838","https://openalex.org/W2410662038","https://openalex.org/W7165843746"],"abstract_inverted_index":{"Background:":[0],"Despite":[1],"varied":[2],"therapeutic":[3],"agents":[4],"used":[5],"to":[6,32,59,251,265],"treat":[7],"patients":[8,72,79,124,132,146,154,177,186,193,208,256,270],"with":[9,73,80,86,144,166,181,257,271],"dermatomyositis":[10,74,84,258],"and":[11,15,52,67,75,83,117,135,149,164,184,238,259,277],"polymyositis":[12,82],"only":[13],"corticosteroids":[14,182],"Acthar":[16,20,36,70,87,200,218,243],"have":[17,125],"FDA":[18],"indications.":[19],"is":[21,263,286],"a":[22,40,96,203,220,248],"porcine":[23],"derived":[24],"ACTH":[25],"containing":[26],"hormone":[27],"which":[28],"has":[29],"been":[30,126,179],"known":[31],"release":[33],"endogenous":[34],"corticosteroids.":[35],"also":[37],"acts":[38],"through":[39],"system":[41],"of":[42,69,109,158,169,199,217,235,274],"melanocortin":[43],"receptors":[44],"widely":[45],"distributed":[46],"throughout":[47],"the":[48,61,129],"immune":[49],"system,":[50],"muscle,":[51],"other":[53],"tissues.":[54],"This":[55],"registry":[56,262],"was":[57,142,289],"undertaken":[58],"study":[60],"patient":[62],"demographics,":[63],"dosing,":[64],"side":[65],"effects,":[66],"efficacy":[68],"in":[71,255],"polymyositis.":[76,260],"Methods:":[77],"Adult":[78],"refractory":[81],"treated":[85,165,180],"were":[88,93,112,187,194,209,223,233],"included.":[89],"Muscle":[90],"biopsy":[91],"slides":[92],"reviewed":[94],"by":[95,291],"blinded":[97],"myopathologist.":[98],"Demographics,":[99],"laboratory":[100],"data,":[101],"strength":[102],"measurements,":[103],"as":[104,106,212,214],"well":[105,253],"validated":[107],"quality":[108],"life":[110],"scores":[111],"collected":[113],"at":[114,244],"baseline,":[115],"3,6,9,":[116],"12":[118,272],"months.":[119],"Results:":[120],"To":[121],"date":[122],"25":[123,192],"enrolled":[127],"into":[128],"registry.":[130],"9":[131],"had":[133,137,155,178],"DM":[134],"16":[136],"PM.":[138],"The":[139,153,228,261],"median":[140],"age":[141],"58":[143],"15":[145],"being":[147,151,173],"female":[148],"10":[150],"male.":[152],"an":[156,167],"average":[157,168],"3.2":[159],"years":[160],"since":[161],"their":[162],"diagnosis":[163],"3.4":[170],"medications":[171],"before":[172],"prescribed":[174],"Acthar.":[175],"23/25":[176],"previously":[183],"6":[185],"on":[188,196,211,268],"concomitant":[189],"steroids.":[190],"All":[191],"started":[195],"80":[197,245],"units":[198,216,246],"subcutaneously":[201],"twice":[202,247],"week.":[204,221],"After":[205],"responding":[206],"many":[207],"maintained":[210],"little":[213],"40":[215],"once":[219,284],"There":[222],"no":[224],"serious":[225],"adverse":[226,231],"events.":[227],"most":[229],"common":[230],"events":[232],"worsening":[234],"glycemic":[236],"control":[237],"lower":[239],"extremity":[240],"edema.":[241],"Conclusion:":[242],"week":[249],"seems":[250],"be":[252],"tolerated":[254],"designed":[264],"collect":[266],"data":[267,283],"100":[269],"months":[273],"follow":[275],"up":[276],"we":[278],"will":[279],"present":[280],"longer":[281],"term":[282],"it":[285],"completed.":[287],"Study":[288],"supported":[290],"Malinckrodt":[292],"Pharmaceuticals":[293]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}